TPIreg

TPIreg was a Canadian regulatory and quality assurance consultancy specializing in supporting pharmaceutical, biotechnology, medical device, natural health product, and cosmetic companies with regulatory strategy and submissions for North America. It was acquired by Innomar Strategies in May 2018 to enhance Innomar’s commercialization services suite. The company did not have its own clinical pipeline but provided strategic support for clients’ drug development programs. Notable work included advising on new drug applications such as CHX Technologies’ Prevora submission to the FDA. Anne Tomalin founded the company in 2013 and joined Innomar Strategies post-acquisition as a leading expert in Canadian regulatory affairs.